Can't disagree and I appreciate the simplistic view that an effective revenue based NR will cause an upward move in the sp but we still are exposed to the risks of supply and demand, market multiples etc etc. So I still advocate an equity play albeit with its dilutive affect to remove any risk of not qualifying for uplisting.